Tipranavir in Complex with a Human Immunodeficiency Virus Type 1 Protease Variant

The higher barrier of darunavir and tipranavir resistance for HIV-1 protease.

PQITLWKRPIVTIKIGGQLKEALLNTGADDTVLEEVNLPGRWKPKLIGGIGGFVKVRQYDQVPIEICGHKVIGTVLVGPT
PTNVIGRNLMTQIGCTLNF

The sequence is a clinical isolate with mutations introduced.

0.1M MES and 2.4M ammonium sulfate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K

Uncomplexed multi-drug resistant HIV-1 protease variant, MDR 769

Uncomplexed multi-drug resistant HIV-1 protease variant, MDR 769 82T

Author states that they are characteristic mutations of the original patient isolate MDR769 HIV-1 protease.

tipranavir, multi-drug resistant HIV-1 protease, HYDORLASE-HYDORLASE INHIBITOR complex

PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEDINLPGRWKPKMIGGIGGFVKVRQYDQVPIEICGHKVIGTVLVGPT
PTNVIGRNLMTQIGCTLNF